Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement
This continuing medical education activity is provided by 
.
Support Statement
This activity is supported by an educational grant from Genentech, Inc.
Target Audience
The intended audience for this activity is gastroenterologists and other health care professionals involved in the management of patients with inflammatory bowel disease (IBD).
Learning Objectives
Upon successful completion of this educational activity, participants should be better able to:
- Summarize how PROs have become important treatment endpoints in the management of IBD.
- Define a clinically meaningful change in PRO as it pertains to evaluating treatment efficacy.
- Compare the use of valid, reliable PRO measures to usual IBD care, including their ability to better achieve patient-centered care and informed decision making.
- Examine PROs that may improve the treatment of IBD by providing expanded information about signs, symptoms, and functional disabilities.
Activity Chair
Peter D.R. Higgins, MD, PhD, MSc
Professor of Internal Medicine
University of Michigan
Ann Arbor, MI
Faculty
Gil Y. Melmed, MD, MS
Professor of Medicine
Director, Inflammatory Bowel Disease Clinical Research
Co-Director, Clinical Inflammatory Bowel Disease
Cedars-Sinai Medical Center
Los Angeles, CA
Megan E, Riehl, PsyD
Assistant Professor
Clinical Psychology, Health Psychologist
Michigan Medicine Gastroenterology Clinic
Taubman Center
Ann Arbor, MI
Patient Advocate
Lindsey Vallender
Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, July 17, 2020, through July 16, 2021.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the activity, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 5 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control.
Activity Chair, Faculty, and Patient Advocate report the following relationship(s)
Peter D.R. Higgins, MD, PhD, MSc
Consulting Fee: AbbVie, Arena, Genentech, Lycera, Pfizer, Takeda
Contracted Research: NIH, Crohn’s & Colitis Foundation
Gil Y. Melmed MD, MS
Consulting Fee:
AbbVie, Boehringer Ingelheim, Bristol-Meyers Squibb, Janssen, Medtronic, Pfizer, Samsung Bioepis, Takeda
Contracted Research:
AbbVie, Gilead, Janssen, Pfizer, Takeda, Theravance
Megan E, Riehl, PsyD
No relevant financial relationships to disclose.
Lindsey Vallender
No relevant financial relationships to disclose.
Reviewer reports the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com